Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease
Open Access
- 13 November 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 35 (1) , 41-55
Abstract
Significance Statement: Long noncoding RNAs (lncRNAs) are a class of nonprotein coding RNAs with pivotal functions in development and disease. They have emerged as an exciting new drug target category for many common conditions. However, the role of lncRNAs in autosomal dominant polycystic kidney disease (ADPKD) has been understudied. This study provides evidence implicating a lncRNA in the pathogenesis of ADPKD. We report that Hoxb3os is downregulated in ADPKD and regulates mammalian target of rapamycin (mTOR)/Akt pathway in the in vivo mouse kidney. Ablating the expression of Hoxb3os in mouse polycystic kidney disease (PKD) activated mTOR complex 2 (mTORC2) signaling and exacerbated the cystic phenotype. The results from our study provide genetic proof of concept for future studies that focus on targeting lncRNAs as a treatment option in PKD. Background: ADPKD is a monogenic disorder characterized by the formation of kidney cysts and is primarily caused by mutations in two genes, PKD1 and PKD2. Methods: In this study, we investigated the role of lncRNA Hoxb3os in ADPKD by ablating its expression in the mouse. Results: Hoxb3os-null mice were viable and had grossly normal kidney morphology but displayed activation of mTOR/Akt signaling and subsequent increase in kidney cell proliferation. To determine the role of Hoxb3os in cystogenesis, we crossed the Hoxb3os-null mouse to two orthologous Pkd1 mouse models: Pkhd1/Cre; Pkd1 F/F (rapid cyst progression) and Pkd1 RC/RC (slow cyst progression). Ablation of Hoxb3os exacerbated cyst growth in both models. To gain insight into the mechanism whereby Hoxb3os inhibition promotes cystogenesis, we performed western blot analysis of mTOR/Akt pathway between Pkd1 single-knockout and Pkd1-Hoxb3os double-knockout (DKO) mice. Compared with single-knockout, DKO mice presented with enhanced levels of total and phosphorylated Rictor. This was accompanied by increased phosphorylation of Akt at Ser473, a known mTORC2 effector site. Physiologically, kidneys from DKO mice displayed between 50% and 60% increase in cell proliferation and cyst number. Conclusions: The results from this study indicate that ablation of Hoxb3os in mouse PKD exacerbates cystogenesis and dysregulates mTORC2.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK116934)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42921)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK116934)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42921)
This publication has 49 references indexed in Scilit:
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expressionGenome Research, 2012
- Calcium-induced Conformational Changes in C-terminal Tail of Polycystin-2 Are Necessary for Channel GatingJournal of Biological Chemistry, 2012
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011
- Long noncoding RNAs and human diseaseTrends in Cell Biology, 2011
- Rictor Phosphorylation on the Thr-1135 Site Does Not Require Mammalian Target of Rapamycin Complex 2Molecular Cancer Research, 2010
- mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 SignalingMolecular and Cellular Biology, 2010
- Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal ciliaHuman Molecular Genetics, 2008
- Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1Human Molecular Genetics, 2008
- Cell biology of polycystin-2Cellular Signalling, 2007
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005